Geriatric Psychopharmacology Flashcards

1
Q

list the 3 cholinesterase inhibitors

A

donepezil

rivastigmine

galantamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the approved AD pharmacotherapies in canada

A

memantine

cholinesterase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how effective are the cholinesterase inhibitors for mild to moderate AD

A

modestly effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how do cholinesterase inhibitors work

A

stop the breakdown of acetylcholine in the synaptic cleft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how does donepezil work

A

NON competitive

reversible

longlasting

once a day morning dose of 5-10 mg

generally well tolerated and easy to use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how does rivastigmine work

A

non competitive

pseudo-irreversible

comes as a patch or capsules (BID dosing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how is rivastigmine metabolized

A

almost totally INDEPENDENT of the hepatic CYP system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how does galantamine ER work

A

BOTH a cholinesterase inhibtor and NICOTINIC receptor modulation

COMPETITIVE inhibition

once daily dosing

side effect profile is similar to donepezil but may be better for anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

patients treated with cholinesterase inhibitors showed less decline on what areas of function

A

overall cognition

memory

naming

executive functions

ADLs

**galantamine reduces caregiver time by ONE HOUR per day in mild to moderate AD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

list dementias that can be treated with cholinesterase inhibitors

A

mild to moderate AD

moderate to severe AD

dementia with lewy bodies

parkinsons disease dementia

vascular/mixed dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

list 3 situations in which you would NOT prescribe a cholinesterase inhibitor

A

normal aging

MCI

fronto-temporal dementia (i.e bvFTD, semantic dementia, progressive nonfluent aphasia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what % of those started on a cholinesterase inhibitor will improve noticeably

A

20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what % of those started on a cholinesterase inhibitor will stay the samw

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what % of those started on a cholinesterase inhibitor will continue to worsen

A

20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what % of those started on a cholinesterase inhibitor will be intolerant of the med

A

10-15%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

list the side effects of cholinesterase inhibitors

A

GI ***

bradycardia

muscle cramps

sleep disturbance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is one way to deal with GI SEs of cholinesterase inhibitors

A

change to Exelon patch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what should you do if a patient on a cholinesterase inhibitor is declining

A

consider alternative med when patient declining, there is caregiver dissatisfaction or there is medication intolerance

can SWITCH cholinesterase inhibitors or ADD MEMANTINE (better to add rather than switch to memenatine monotherapy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the role of glutamate in AD

A

INCREASED activity at glutamate synapses

leads to TONIC MILD ACTIVATION at NMDA receptors

leads to neuronal death following CHRONIC INSULT and cognitive deficit due to decrease in SIGNAL TO NOISE ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

how does memantine work

A

voltage dependent

low to moderate affinity

UNcompetitive NMDA receptor antagonist

acts SELECTIVELY at NMDA receptors

NO significant affinity for other receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

how is memantine metabolized

A

undergoes LITTLE metabolism

majority is excreted UNCHANGED via the KIDNEYS (75-90%) with long half life (60-80 hours)

no role for cyp system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what behaviours improved with addition of memantine

A

agitation/aggression

irritability/lability

apathy/indifference

appetite/eating changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

when should you use memantine

A

moderate to severe AD–> MMSE typically under 16, needs regular prompting for basic ADLs

combined therapy with cholinesterase inhibitors preferred

useful for reducing agitation

consider in MILD AD if INTOLERANT of all cholinesterase inhibitors or they are contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

do you have to adjust memantine in renal or hepatic impairment

A

not for hepatic

yes for renal (half of typical maintenance dose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
does memantine have significant drug interactions
no, minimal
26
list side effects of memantine
minimal can have some dizziness, maybe confusion at week 4/change in bowel patterns/overactivation
27
how do you stage AD
by MMSE: above 22--> mild 18-22--> mild to moderate 13-17--> moderate 8-16--> moderate to severe less than 8--> severe
28
is trial discontinuation recommended for AD meds
no
29
why is it tricky to prescribe meds in geriatrics
1. polypharmacy--> higher risk of interactions 2. changes in physiology--> higher risk of SEs 3. comorbidities--> higher risk of SEs
30
how does age impact sensitivity to benzos
the elderly have increased sensitivity to the CNS effects of benzos
31
why are older people at higher risk of bleeding (including as SE from meds)
greater INHIBITION of vitamin K dependent clotting factors --> increased risk of bleeding
32
why are the elderly at greater risk of hypotension due to meds
increased sensitivity to negative inotropic and vasodilator + diminished baroreceptor sensitivity
33
is there a criteria to judge potentially inappropriate medication use in older adults
Beers criteria
34
why do Beers criteria recommend avoiding antipsychotics in the elderly
increased risk of CVA greater risk of cognitive decline and mortality in persons with dementia
35
why do the Beers criteria recommend avoiding benzos in the elderly
all increase risk of cognitive impairment, delirium, falls, fractures, and MVAs in older adults
36
in which cases would you consider benzos in the elderly per the Beers criteria
seizure disorders REM sleep behaviour disorders benzo or etoh withdrawal severe GAD perioperational anesthesia
37
do the Beers criteria recommend benztropine for treating EPS in the elderly
no--> say there are better agents
38
why do the Beers criteria recommend avoiding Z drugs
adverse events similar to benzos in the elderly increased ER visits and hospitalizations increase MVAs minimal improvement in sleep latency and duration
39
list medications that may cause SIADH or hyponatremia (esp in the elderly)
antipsychotics carbamanzepine diuretics mirtazapine oxcarbazapine SNRIs SSRIs TCAs tramadol
40
list medications that should be avoided in older adults with, or who are at high risk for, delirium (i.e are deliriogenic)
anticholinergics antipsychotics benzos corticosteroids H2 receptor antagonists (i.e cimetidine, famotidine, ranitidine, nizatidine) meperidine Z drugs
41
name a non-psych class of meds that should be avoided in parkinsons disease
antiemetics like metoclopramide as they are dopamine receptor antagonists with potential to worsen parkinsons symptoms
42
which dopamine receptor antagonists appear to be less likely to precipitate worsening of parkinsons disease
pimavanserin clozapine *quetiapine has low quality evidence
43
are there significant changes to absorption of medications with age
no, change with age is negligible (i.e gastric pH, GI motility, intestinal permeability, drug transporters, GI blood flow)
44
what are the two factors that determine distribution of drugs
protein binding and volume of distribution
45
how does protein binding change with age
decreased albumin--> decreased protein binding leads to MORE FREE DRUG in geri populations
46
how does volume of distribution change with age
INCREASED BODY FAT --> increased volume of distribution for LIPOPHILIC drugs i.e depot antipsychotics DECREASED BODY WATER--> volume of distribution is decreased for HYDROPHILIC drugs (i.e lithium)
47
how does liver metabolism change with age
hepatic volume and blood flow are decreased and thus CYP enzyme system is DECREASED (this is phase I metabolism) phase II metabolism is NOT similarly affected
48
how does renal excretion change with age
decreases/is slower --> drug interactions with CYP system can compound this problem
49
list 4 psych meds that need to be adjusted for renal clearance in older adults
duloxetine gabapentin keppra pregabalin
50
in older adults, what meds should you NOT combine with: opioids
benzos gabapentin, pregabalin *risks of overdose/sedation related events
51
in older adults, what meds should you NOT combine with: lithium
loop diuretics ACEIs due to risk of Li toxicity
52
why should you make sure to minimize anticholinergic med burden in the elderly
risk of cognitive decline
53
which has higher risk of GI bleed--> NSAIDs or SSRIs
NSAIDs--> but combo of SSRI + NSAID increases the risk by about double
54
what are the big SEs of cognitive enhancers (cholinesterase inhibitors)
GI--> vomiting and nausea (also falls, syncope, dizziness/confusion, bradycardia etc)
55
what are the 3 classes of psychotropic medications that are most implicated in higher risk of falls in the elderly
sedative/hypnotics antidepressants antipsychotics *these have higher risk than antihypertensives, beta blockers, NSAIDs, narcotics, etc
56
who is more likely to fall--men or women
female gender is risk factor for falls
57
how does the risk for falls change overtime in older people on TCAs
DECREASES over time
58
how does the risk for falls change overtime in older people on SSRIs
INCREASES over time
59
what makes SSRIs particularly risky for falls
implicated in decreasing bone density by about 3-6% thus also increasing risk for fracture with falls
60
is risk of stroke higher with atypical or typical APs
higher with atypical and also higher if have dementia
61
list SSRIs and others that can cause QTc prolongation
citalopram escitalopram fluoxetine mirtazapine paroxetine sertraline trazodone venlafaxine
62
what street drug prolongs QTc
cocaine
63
why should be careful with benztropine in the elderly
anticholinergic
64
list 5 risk factors for SIADH
older age female gender concomitant use of diuretics low body weight lower baseline serum sodium
65
list 3 major drug classes identified as potential precipitants of lithium toxicity
renal sodium wasting diuretics ACEI NSAIDs
66
what lithium level do more geri psych people aim for
0.4-0.6mmol/L no good studies
67
do the risks of dystonia or akathesia change in the elderly
no--> dystonia is unlikely in the elderly and akathesia has same risk as general population (20-40%)
68
how does the risk of parkinsonism as side effect change with age
above 50% to as high as 76% in age above 60
69
how does the risk of tardive dyskinesia change with age
higher risk than in younger adults--depends on population (ie higher risk in institutionalized settings)
70
what kind of medication is pramipexole
dopamine receptor AGONIST
71
what type of medication in memantine
NMDA receptor ANTagonist
72
what kind of medication is galantamine
cholinesterase inhibitor
73
what kind of medication is donepezil
cholineserase inhibitor
74
what kind of medication is bromocriptine
dopamine agonist
75
what kind of medication is ropirinol
dopamine agonist
76
what kind of medication is rivastigmine
cholinesterase inhibitor
77
what kind of medication is amantadine
dopamine agonist
78
3 indications for bromocriptine
1. NMS (off label) 2. hyperprolactinemia 3. parkinsons
79
5 side effects of bromocriptine
1. NVD 2. pulmonary fibrosis 3. pleural effusion 4. hypotension 5. psychosis
80
what other receptors dow bromocriptine bind to other than domapine
serotonin alpha/beta adrenergic
81
what is an indication for ropinirole
restless legs (rarely, augmentation in TR depression)
82
side effects of ropinirole
NVD orthostatic hypotension headache dizziness arrythmia sleep attacks psychosis
83
indication for pramipexole
parkinsons (rarely, augmentation in TR depression)
84
side effects of pramipexole
NVD orthostatic hypotension headache dizziness arrythmia sleep attacks psychosis
85
which of the dopamine agonists binds D3 more than D2
ropinirole + pramipexole
86
how does pramipexole affect sleep
improves sleep architecture *also is neuroprotective and has antidepressant effects
87
4 indications for amantadine
1. parkinsons 2. restless legs 3. TBI 4. EPS (rarely in severe cocaine withdrawal)
88
which of the dopamine agonists can be used to treat restless legs
ropinirole amantadine
89
which of the dopamine agonists can be used to treat cocaine withdrawal
amantadine *rare, withdrawal must be severe
90
which dopamine agonist should you not discontinue abruptly
amantadine
91
what other receptors does amantadine work on other than dopamine
NMDA antagonist anticholinergic
92
what medication is an alternative to benztropine if they cant tolerate a strong anticholinergic like benztropine
amantadine
93
what dopamine agonist must you use renal dosing with
amantadine
94
side effects of amantadine
dizziness nausea insomnia irritability psychosis hypotension livedo reticularis
95
indications for memantine
moderate to severe AD +/- vascular *not indicated for other dementias
96
which has fewer GI side effects, donepezil or rivastigmine
donepezil
97
which of the cholinesterase inhibitors is best for parkinsons
rivastigmine
98
which of the cholinesterase inhibitor is best for vascular dementia
donepezil
99
which cholinesterase inhibitors can reduce AH/VH in parkinsons dementia/LBD
all of them
100
where in the brain do cholinesterase inhibitors increase acetylcholine
in the hippocampus and the cortex
101
list side effects of the cholinesterase inhibitors
NVD weight loss bradycardia syncope fatigue insomnia nightmares muscle cramps